InvestorsHub Logo
Followers 19
Posts 1082
Boards Moderated 0
Alias Born 03/09/2014

Re: None

Tuesday, 04/15/2014 10:26:20 PM

Tuesday, April 15, 2014 10:26:20 PM

Post# of 140464
With potential and history of a similar company on our side, and with the upper management getting paid in stock, I can't imagine that to end it all with a buy out at 30 would be satisfying. If we were that far, the rest is also history if the company starts to go it alone. The initial sales year will be huge! SOOO many of the surgeons I work with would be eager to buy anything other than another ISRG product... Sales will be large with just the connections they are making now! Both here and internationally. In less than 7 years ISRG stock was above 200! With the patent for only one procedure pretty much... Titan will get there 2-4 times as fast with multiple procedure patents and history of ISRG. That is a number worth waiting for!!
When I talk to physicians at my hospital about this single SPORT robot: expanding day surgery (which is currently being taken away by competing surg centers), being useful in ICUs, and assisting the smaller rural hospitals to consult with us (and making money) remotely, they grin hugely at the true change the SPORT can make.
It is all about cost containment and liability... And this product has what it takes to make that happen in so many more ways than a large platform robot.
Because we have two DaVInci systems certainly does not mean that we will automatically go with ISRG. There is too much discontent with the company...